{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:03:20Z","timestamp":1777892600795,"version":"3.51.4"},"reference-count":56,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Royal College of Physicians of Edinburgh"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Globally, the prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly and constitutes a significant healthcare burden due to associated complications including hepatic (cirrhosis and hepatocellular cancer) and non-hepatic (cardiovascular deaths) disorders. It is closely linked to insulin resistance and metabolic syndrome but moderate alcohol consumption frequently coexists. Recently, genetic polymorphisms were implicated in the development of non-obese NAFLD. Apart from liver biopsy, in order to assess for steatosis, fibrosis and non-alcoholic steatohepatitis (NASH), advances in non-invasive serum tests and elastography have provided similarly accurate, more accessible and safer alternatives for risk stratification. As for treatment in 2020, weight loss and lifestyle modification remain the central strategy. Unfortunately, no pharmacological agents have been approved thus far, but there are a number of potential therapies in the pipeline for fibrosis and NASH. Treatment of underlying metabolic disorders is important. While the term NAFLD was coined in the 1980s, more recent understanding may support a change in nomenclature highlighting its strong metabolic roots.<\/jats:p>","DOI":"10.4997\/jrcpe.2020.308","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T05:53:01Z","timestamp":1599803581000},"page":"256-261","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and Management of Fatty Liver"],"prefix":"10.1177","volume":"50","author":[{"given":"Phei Oon","family":"Tan","sequence":"first","affiliation":[{"name":"Gastroenterology Fellow, Gastroenterology Division, Department of Medicine, Hospital Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazri","family":"Mustaffa","sequence":"additional","affiliation":[{"name":"Consultant Physician, Gastroenterologist & Hepatologist, Gastroenterology Division, Department of Medicine, Hospital Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soek Siam","family":"Tan","sequence":"additional","affiliation":[{"name":"Senior Consultant Hepatologist, Department of Hepatology, Selayang Hospital, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong Yeh","family":"Lee","sequence":"additional","affiliation":[{"name":"Professor of Medicine, Gastroenterology & Hepatology, Gastroenterology Division, Department of Medicine, Hospital Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"bibr1-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0316-6"},{"key":"bibr2-jrcpe.2020.308","first-page":"1388","volume":"64","author":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","year":"2016","journal-title":"J Hepatol"},{"key":"bibr3-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14478"},{"key":"bibr4-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v8.i3.100"},{"key":"bibr5-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27490"},{"key":"bibr6-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23622"},{"key":"bibr7-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2019.09.08"},{"key":"bibr8-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"bibr9-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29466"},{"key":"bibr10-jrcpe.2020.308","first-page":"167","volume":"11","author":"Nassir F","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"bibr11-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"bibr12-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-2-200001180-00004"},{"key":"bibr13-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802555991"},{"key":"bibr14-jrcpe.2020.308","doi-asserted-by":"crossref","unstructured":"Alberti KG, Eckel RH, Grundy SM. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640\u20135.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"bibr15-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-28032010000200009"},{"key":"bibr16-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0912063"},{"key":"bibr17-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.3390\/nu5051544"},{"key":"bibr18-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26156"},{"key":"bibr19-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2013.09.009"},{"key":"bibr20-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12038"},{"key":"bibr21-jrcpe.2020.308","unstructured":"World Health Organisation. Waist circumference and waist\u2013 hip ratio: report of a WHO expert consultation, Geneva, 8\u201311 December 2008. Geneva: WHO; 2011."},{"key":"bibr22-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7570.695"},{"key":"bibr23-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.014"},{"key":"bibr24-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1456_17"},{"key":"bibr25-jrcpe.2020.308","doi-asserted-by":"crossref","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med 2017; 15:45. https:\/\/doi.org\/10.1186\/s12916-017-0806-8.","DOI":"10.1186\/s12916-017-0806-8"},{"key":"bibr26-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26986"},{"key":"bibr27-jrcpe.2020.308","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"Franchis R","year":"2015","journal-title":"J Hepatol"},{"key":"bibr28-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22742"},{"key":"bibr29-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-019-00493-x"},{"key":"bibr30-jrcpe.2020.308","first-page":"17654","volume":"8","author":"Wang Y","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"bibr31-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21984"},{"key":"bibr32-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.72.853.10341686"},{"key":"bibr33-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.23585"},{"key":"bibr34-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.883601"},{"key":"bibr35-jrcpe.2020.308","volume":"9","author":"Li Y","year":"2014","journal-title":"PLoS One"},{"key":"bibr36-jrcpe.2020.308","author":"Adams LA","year":"2020","journal-title":"Semin Liver Dis"},{"key":"bibr37-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2017.11.003"},{"key":"bibr38-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0856"},{"key":"bibr39-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.03.019"},{"key":"bibr40-jrcpe.2020.308","doi-asserted-by":"crossref","unstructured":"Johari MI, Yusoff K, Haron J. A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease. Sci Rep 2019; 9: 11232. https:\/\/doi.org\/10.1038\/s41598-019-47763-8.","DOI":"10.1038\/s41598-019-47763-8"},{"key":"bibr41-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.06.010"},{"key":"bibr42-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.012"},{"key":"bibr43-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2013.09.009"},{"key":"bibr44-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.024"},{"key":"bibr45-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12304"},{"key":"bibr46-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.014"},{"key":"bibr47-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929"},{"key":"bibr48-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00803-X"},{"key":"bibr49-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"bibr50-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-019-00020-1"},{"key":"bibr51-jrcpe.2020.308","unstructured":"Gawrieh S, Noureddin M, Loo NM. A phase 2, prospective, multicentre, double-blind, randomized study of saroglitazar magnesium 1mg, 2mg or 4mg versus placebo in patients with non-alcoholic fatty liver disease and\/or nonalcoholic steatohepatitis (EVIDENCES IV). AASLD The Liver Meeting 2019, November 8-12, Boston MA, Abstract L010. https:\/\/www.aasld.org\/sites\/default\/files\/2019-10\/2019-TLM-LateBreakingAbstracts.pdfhttps:\/\/www.aasld.org\/sites\/default\/files\/2019-10\/2019-TLM-LateBreakingAbstracts-v2.pdf (accessed 23\/7\/20)."},{"key":"bibr52-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1080\/00365520902845268"},{"key":"bibr53-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.006"},{"key":"bibr54-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.014"},{"key":"bibr55-jrcpe.2020.308","first-page":"397","volume":"12","author":"Lim JK","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"bibr56-jrcpe.2020.308","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.026"}],"container-title":["Journal of the Royal College of Physicians of Edinburgh"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/jrcpe.2020.308","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4997\/jrcpe.2020.308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:33:17Z","timestamp":1777617197000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4997\/jrcpe.2020.308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.4997\/jrcpe.2020.308"],"URL":"https:\/\/doi.org\/10.4997\/jrcpe.2020.308","relation":{},"ISSN":["1478-2715","2042-8189"],"issn-type":[{"value":"1478-2715","type":"print"},{"value":"2042-8189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}